aspirin has been researched along with valproic acid in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (17.31) | 18.7374 |
1990's | 7 (13.46) | 18.2507 |
2000's | 18 (34.62) | 29.6817 |
2010's | 16 (30.77) | 24.3611 |
2020's | 2 (3.85) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Pisani, F | 1 |
Keller, BJ; Thurman, RG; Yamanaka, H | 1 |
Garcia de la Serrana, H; Mota, C; Puche, E; Saucedo, R | 1 |
Glötzner, FL; Lorz, U | 1 |
Abbott, FS; Farrell, K; Kassam, J; Orr, JM | 1 |
Camfield, PR; Dooley, JM; Fraser, AD; Goulden, KJ | 1 |
Kolts, BE; Langfitt, M | 1 |
Berlin, CM | 1 |
Holtzman, JL | 1 |
Abbott, FS; Farrell, K; Ferguson, S; Godolphin, W; Orr, JM; Sheppard, I | 1 |
Abbott, FS; Bruni, J; Farrell, K; Ferguson, S; Godolphin, W; Orr, JM; Sheppard, I | 1 |
Goadsby, PJ; Kaube, H | 1 |
Guieu, R; Kopeyan, C; Rochat, H | 1 |
Lemasters, JJ; Trost, LC | 1 |
Annoni, JM; Higelin, F | 1 |
Cartigny, B; Imbenotte, M; Lhermitte, M; Vermeersch, G | 1 |
Gupta, YK; Srivastava, AK | 1 |
Imataka, G; Yamanouchi, H | 1 |
Bethke, F; Droste, DW; Flöel, A; Imai, T; Lohmann, H; Sunderkötter, C | 1 |
Gejyo, F; In, H; Ito, S; Izumi, J; Kanazawa, M; Nakano, M; Ohno, T; Tanaka, H; Ueno, M; Wada, Y; Yahata, K | 1 |
Diener, HC; Leniger, T; Limmroth, V; Pageler, L; Stude, P | 1 |
Dyszkiewicz-Korpanty, AM; Frenkel, EP; Sarode, R | 1 |
Arakawa, Y; Hashimoto, N; Kikuta, K; Miyamoto, S; Takagi, Y | 1 |
Bourke, DL; Marcucci, C; Sandson, NB; Smith-Lamacchia, R | 1 |
Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K | 1 |
Penot, JP; Pradeau, F | 1 |
de Leon, J; Fleming, MW; Kiesel, JL; Strobl, B | 1 |
Aissi, M; Boughammoura-Bouatay, A; Frih-Ayed, M; Jerbi-Ommezzine, S; Sfar, MH; Younes-Mhenni, S | 1 |
Bonomi, A; Cavicchini, L; Ciusani, E; Coccè, V; Gribaldo, L; Pessina, A; Sisto, F | 1 |
Dubuisson, N; Dupuis, F; Dupuis, M; Evrard, F; van Rijckevorsel, K; Van Robays, P | 1 |
Cheng, KW; Constantinides, PP; Rigas, B; Wong, CC; Xie, G; Zhou, D; Zhu, CH | 1 |
Chen, Y; He, H; Li, X; Lou, L; Wang, J; Ye, W; Zhu, Y | 1 |
Cooley, AT; de Leon, J; Riesselman, A; Strobl, B | 1 |
Liu, L; Qu, X; Wang, P; Wang, X; Zeng, H; Zhu, H; Zhu, X | 1 |
Batchelor, LK; Biancalana, L; Bortoluzzi, M; Dyson, PJ; Funaioli, T; Marchetti, F; Pampaloni, G; Zacchini, S | 1 |
Araujo, M; Benevent, J; Damase-Michel, C; Durrieu, G; Foch, C; Lacroix, I; Montastruc, JL; Weckel, A | 1 |
Fasbender, F; Hengstler, JG; Metzler, S; Obholzer, M; Stöber, R; Watzl, C | 1 |
7 review(s) available for aspirin and valproic acid
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Influence of co-medication on the metabolism of valproate.
Topics: Anticonvulsants; Aspirin; Biotransformation; Drug Interactions; Humans; Liver; Oxidation-Reduction; Valproic Acid | 1992 |
Advances in pediatric pharmacology and toxicology.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Attention Deficit Disorder with Hyperactivity; Biological Availability; Child; Child, Preschool; Female; Fetus; Humans; Infant; Infant, Newborn; Kinetics; Maternal-Fetal Exchange; Metoclopramide; Otitis Media; Otitis Media with Effusion; Pediatrics; Pharmaceutical Preparations; Pharmacology; Phenobarbital; Pregnancy; Reye Syndrome; Salamandridae; Seizures; Tourette Syndrome; Toxicology; Valproic Acid | 1983 |
Medical treatment of migraine: from mechanisms of action to contraindications.
Topics: Acetaminophen; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Female; Humans; Male; Migraine Disorders; Serotonin Receptor Agonists; Valproic Acid | 1998 |
[Mitochondrial diseases due to drug toxicity].
Topics: Animals; Antibiotics, Antineoplastic; Aspirin; Humans; Mitochondria; Mitochondrial Diseases; Reye Syndrome; Valproic Acid | 2002 |
Takotsubo syndrome (TKS): a possible mechanism of sudden unexplained death in epilepsy (SUDEP).
Topics: Adrenergic beta-1 Receptor Antagonists; Anticonvulsants; Aspirin; Bisoprolol; Death, Sudden; Epilepsy; Female; Fibrinolytic Agents; Humans; Lamotrigine; Middle Aged; Perindopril; Takotsubo Cardiomyopathy; Triazines; Valproic Acid | 2012 |
1 trial(s) available for aspirin and valproic acid
Article | Year |
---|---|
Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks.
Topics: Acute Disease; Analgesics; Aspirin; Double-Blind Method; GABA Agents; Humans; Infusions, Intravenous; Lysine; Migraine Disorders; Treatment Outcome; Valproic Acid | 2005 |
44 other study(ies) available for aspirin and valproic acid
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents.
Topics: Animals; Aspirin; Cell Division; Clofibrate; Clofibric Acid; Dose-Response Relationship, Drug; Female; Fibric Acids; Hypolipidemic Agents; L-Lactate Dehydrogenase; Microbodies; Mitochondria, Liver; Oxygen Consumption; Rats; Rats, Inbred Strains; Trypan Blue; Valproic Acid | 1992 |
Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid.
Topics: Adult; Anticonvulsants; Aspirin; Carbamazepine; Epilepsy; Esterases; Female; Humans; Male; Phenobarbital; Phenytoin; Valproic Acid | 1989 |
[Reye syndrome treated with valproic acid in association with varicella infection].
Topics: Adult; Aspirin; Carbamazepine; Chickenpox; Drug Therapy, Combination; Epilepsy; Humans; Male; Reye Syndrome; Risk Factors; Valproic Acid | 1989 |
The effect of aspirin on valproic acid metabolism.
Topics: Adolescent; Adult; Aspirin; Child; Child, Preschool; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Male; Valproic Acid | 1986 |
Clinical valproate toxicity induced by acetylsalicylic acid.
Topics: Adolescent; Aspirin; Child; Child, Preschool; Drug Interactions; Epilepsy, Temporal Lobe; Female; Humans; Hyperkinesis; Male; Nystagmus, Pathologic; Paranoid Disorders; Tremor; Valproic Acid | 1987 |
Drugs and the liver.
Topics: Acetaminophen; Adult; Aspirin; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Cholestasis; Cimetidine; Fatty Liver; Female; Hepatic Artery; Hepatic Veins; Humans; Ketoconazole; Liver; Liver Diseases; Liver Neoplasms; Methyldopa; Necrosis; Nitrofurantoin; Peliosis Hepatis; Portal Vein; Valproic Acid; Verapamil | 1984 |
Definition and implications of dose-dependent kinetics in clinical medicine.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; Ethanol; Humans; Kinetics; Lidocaine; Pharmaceutical Preparations; Phenytoin; Valproic Acid | 1983 |
Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects.
Topics: Aspirin; Blood Proteins; Child; Child, Preschool; Drug Interactions; Epilepsy; Female; Humans; Kinetics; Male; Protein Binding; Salicylates; Valproic Acid | 1982 |
The effect of acetylsalicylic acid on serum free valproate concentrations and valproate clearance in children.
Topics: Administration, Oral; Adolescent; Aspirin; Child; Child, Preschool; Humans; Protein Binding; Valproic Acid | 1982 |
Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat.
Topics: Analgesics; Animals; Aspirin; Cats; Cerebral Cortex; Clonazepam; Cortical Spreading Depression; Dihydroergotamine; Dizocilpine Maleate; Female; Halothane; Lidocaine; Metoprolol; Migraine Disorders; Receptors, N-Methyl-D-Aspartate; Regional Blood Flow; Ultrasonography, Doppler, Transcranial; Valproic Acid | 1994 |
Utilization of aspirin, quinine and verapamil in the prevention and treatment of scorpion venom intoxication.
Topics: Animals; Aspirin; Female; gamma-Aminobutyric Acid; Lethal Dose 50; Mice; Mice, Inbred C57BL; Poisoning; Quinine; Scorpion Venoms; Valproic Acid; Verapamil | 1993 |
The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.
Topics: Animals; Aspirin; Carboxylic Acids; Chemical and Drug Induced Liver Injury; Cyclosporine; Male; Membrane Potentials; Mitochondria, Liver; Mitochondrial Swelling; Rats; Rats, Sprague-Dawley; Reye Syndrome; Ruthenium Red; Structure-Activity Relationship; Valproic Acid | 1996 |
[Identification and quantification of exogenous metabolites in biological liquids with new development in NMR spectroscopy in one and two dimensions].
Topics: Adolescent; Adult; Analgesics; Anticonvulsants; Antimalarials; Aspirin; Chloroquine; Female; Humans; Lysine; Magnetic Resonance Spectroscopy; Male; Poisoning; Reproducibility of Results; Valproic Acid | 1999 |
Aspirin modulates the anticonvulsant effect of diazepam and sodium valproate in pentylenetetrazole and maximal electroshock induced seizures in mice.
Topics: Animals; Anticonvulsants; Aspirin; Diazepam; Male; Mice; Pentylenetetrazole; Prostaglandins; Seizures; Valproic Acid | 2001 |
Therapy of Sneddon syndrome.
Topics: Adult; Antibodies, Antiphospholipid; Anticonvulsants; Aspirin; Azathioprine; Clopidogrel; Drug Therapy, Combination; Epilepsy; Female; Humans; Immunosuppressive Agents; Platelet Aggregation Inhibitors; Sneddon Syndrome; Ticlopidine; Valproic Acid | 2002 |
Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report.
Topics: Antibodies, Antineutrophil Cytoplasmic; Arteriosclerosis; Aspirin; Autoantibodies; Cholesterol, LDL; Female; Granulomatosis with Polyangiitis; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Mixed Connective Tissue Disease; Myeloblastin; Prednisolone; Probucol; Serine Endopeptidases; Treatment Outcome; Valproic Acid | 2004 |
Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods.
Topics: Adolescent; Adult; Aspirin; Blood Platelets; Child; Clopidogrel; Diagnostic Tests, Routine; Electric Impedance; Humans; Male; Middle Aged; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Sensitivity and Specificity; Ticlopidine; Valproic Acid | 2005 |
Absence epilepsy associated with moyamoya disease. Case report.
Topics: Anticonvulsants; Aspirin; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Cerebral Infarction; Cerebral Revascularization; Child; Child, Preschool; Combined Modality Therapy; Drug Resistance; Electroencephalography; Epilepsy, Absence; Female; Follow-Up Studies; Frontal Lobe; Humans; Moyamoya Disease; Postoperative Complications; Tomography, Emission-Computed, Single-Photon; Valproic Acid | 2006 |
An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions.
Topics: Aged; Anticonvulsants; Aspirin; Blood Proteins; Dizziness; Drug Interactions; Drug Monitoring; Humans; Male; Valproic Acid | 2006 |
Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale.
Topics: Aspirin; Blood Transfusion, Intrauterine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobinopathies; Humans; Medroxyprogesterone; Models, Biological; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Valproic Acid | 2007 |
[Iatrogenic dementia and extrapyramidal syndrome: rare adverse effect of valproic acid-aspirin combination].
Topics: Aged; Anticonvulsants; Aspirin; Basal Ganglia Diseases; Dementia; Drug Interactions; Drug Therapy, Combination; Humans; Iatrogenic Disease; Male; Platelet Aggregation Inhibitors; Rare Diseases; Valproic Acid | 2010 |
Valproic acid toxicity associated with low dose of aspirin and low total valproic acid levels: a case report.
Topics: Aspirin; Dose-Response Relationship, Drug; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Middle Aged; Protein Binding; Seizures; Valproic Acid | 2009 |
[Tuberous sclerosis and intracranial aneurysms: a rare association].
Topics: Adult; Anticonvulsants; Aspirin; Carbamazepine; Carotid Artery Diseases; Humans; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors; Tuberous Sclerosis; Valproic Acid | 2010 |
A mesenchymal stromal cell line resistant to paclitaxel that spontaneously differentiates into osteoblast-like cells.
Topics: Adipocytes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Aspirin; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Cells; Cell Cycle; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Chondrocytes; Drug Resistance, Neoplasm; Female; Humans; Indomethacin; Mesenchymal Stem Cells; Mice; Osteoblasts; Paclitaxel; Valproic Acid | 2011 |
Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Line, Tumor; Cell Survival; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; HEK293 Cells; Humans; Hydrolysis; Ibuprofen; Indomethacin; Inhibitory Concentration 50; Kinetics; Mice; Mice, Inbred BALB C; Mice, Nude; Naproxen; Nitrophenols; Organophosphates; Organophosphorus Compounds; Phenylglyoxal; Stomach Neoplasms; Sulindac; Transfection; Valproic Acid; Xenograft Model Antitumor Assays | 2012 |
Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Aspirin; Blotting, Western; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Drug Synergism; Gene Expression; Hep G2 Cells; Histone Deacetylase Inhibitors; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Tumor Burden; Valproic Acid; Xenograft Model Antitumor Assays | 2013 |
A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aspirin; Bipolar Disorder; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Valproic Acid | 2013 |
As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.
Topics: Arsenic Trioxide; Arsenicals; Aspirin; Cells, Cultured; Dose-Response Relationship, Drug; Genes, Reporter; HEK293 Cells; HIV Long Terminal Repeat; HIV-1; Humans; Jurkat Cells; Leukocytes, Mononuclear; Microscopy, Fluorescence; NF-kappa B; Oxides; Phorbol Esters; Signal Transduction; Transfection; Tumor Necrosis Factor-alpha; Valproic Acid; Virus Activation; Virus Latency | 2013 |
α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes.
Topics: Antineoplastic Agents; Aspirin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Cymenes; Drug Stability; Electrochemical Techniques; Humans; Imines; Ligands; Models, Chemical; Monoterpenes; Quantum Theory; Ruthenium; Solubility; Valproic Acid; Water | 2018 |
In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Aspirin; Case-Control Studies; Child, Preschool; Databases, Factual; Female; France; Glucocorticoids; Hearing Loss; Humans; Male; Otitis Media; Pregnancy; Prenatal Exposure Delayed Effects; Valproic Acid | 2018 |
Enhanced activation of human NK cells by drug-exposed hepatocytes.
Topics: Antibodies, Neutralizing; Aspirin; Chemical and Drug Induced Liver Injury; Coculture Techniques; Cytotoxicity Tests, Immunologic; Gene Expression Regulation; Hepatocytes; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Isoniazid; Ketoconazole; Killer Cells, Natural; Natural Cytotoxicity Triggering Receptor 3; NK Cell Lectin-Like Receptor Subfamily K; Valproic Acid | 2020 |